What to know about the new Novavax vaccine for COVID-19 ...Middle East

The Hill - News
What to know about the new Novavax vaccine for COVID-19
Story at a glance The Maryland-based company Novavax has a COVID-19 vaccine that is approved for emergency use internationally but not yet in the U.S. The FDA’s Advisory Committee has recommended it be granted emergency use authorization. The manufacturing process follows more traditional vaccine production and can be slower to build up supply. Last week, the Federal Drug Administration’s (FDA) advisory committee recommended that Nuvaxovid receive emergency use authorization for people aged 18 and over. Outside of the U.S., the Novavax COVID-19 vaccine, named Nuvaxovid, has received use authorization in more than 40 countries and is listed for emergency use by

Hence then, the article about what to know about the new novavax vaccine for covid 19 was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( What to know about the new Novavax vaccine for COVID-19 )

Apple Storegoogle play

Last updated :

Also on site :



Latest News